Home Featured 2

Featured 2

Featured posts

Latest

Expanding Efforts Help Address Disparities in Lung Cancer Care

lungcanc

SHAWL: Largest Study of Its Kind Evaluates Sexual Dysfunction in Women With Lung Cancer

Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in NSCLC

Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

Lorlatinib in ROS1-Positive NSCLC: A Review of Recent Data

Lung Cancer Global Mortality Projections Skyrocket for Women

lungcanc

Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung...

lungcanc

Lung Cancer Pathology Pioneer Dr. Adi Gazdar Dies at 81

lungcanc

The Changing the Landscape of Tobacco Products: Potential Effects of ENDS...

lungcanc

Diagnostic Oncology: Reports from the IASLC Pathology Committee

lungcanc

Dr. Jamie E. Chaft Discusses Emerging Data on Induction Immunotherapy for...

lungcanc

An Interview with Dr. Federico Cappuzzo: Checkpoint Inhibitors Have Replaced Old...

lungcanc

Ongoing Clinical Challenges: Defining Immunotherapy Benefit for Patients With NSCLC and...

lungcanc

1...5 67Page 7 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib